Corium to Present at Upcoming Investor Conferences
February 07, 2017 16:05 ET
|
Corium International, Inc.
MENLO PARK, Calif., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Report First Quarter Fiscal Year 2017 Financial Results on Monday, February 13, 2017
February 06, 2017 16:05 ET
|
Corium International, Inc.
MENLO PARK, Calif., Feb. 06, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the first quarter ended December 31, 2016...
Corium Prices Follow-On Offering of Common Stock
February 02, 2017 08:30 ET
|
Corium International, Inc.
MENLO PARK, Calif., Feb. 02, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Announces Proposed Public Offering of Common Stock
February 01, 2017 16:23 ET
|
Corium International, Inc.
MENLO PARK, Calif., Feb. 01, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Reports Fourth Quarter and Fiscal Year 2016 Financial Results and Recent Corporate Highlights
November 21, 2016 16:02 ET
|
Corium International, Inc.
MENLO PARK, Calif., Nov. 21, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Report Fourth Quarter and Year-end Fiscal Year 2016 Financial Results on Monday, November 21, 2016
November 15, 2016 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the fourth quarter and fiscal year (FY)...
Corium to Present at Dawson James Securities Growth Stock Conference
October 13, 2016 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Announces Streamlined Bioequivalence Development Path for Transdermal Corplex™ Memantine
August 24, 2016 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., Aug. 24, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Reports Third Quarter Fiscal 2016 Financial Results and Recent Corporate Highlights
August 04, 2016 16:01 ET
|
Corium International, Inc.
MENLO PARK, Calif., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Report Third Quarter Fiscal Year 2016 Financial Results on Thursday, August 4, 2016
July 28, 2016 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., July 28, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the third fiscal quarter ended June 30,...